Adlai Nortye Biopharma Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Hangzhou http://www.adlainortye.com/en_about.php China (2014)

Organization Overview

First Clinical Trial
2020
NCT04432857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adlai Nortye | Adlai Nortye Biopharma Co., Ltd. | Adlai Nortye USA Inc | ADLAI NORTYE USA INC. | Adlai Nortye US Inc